Stocks News

LAST PRICE
45.6500
TODAY'S CHANGE (%)
Trending Down-8.3100 (-15.4003%)

Bid / Lots
45.7500/ 10
Ask / Lots
45.9000/ 1
Open / Previous Close
48.8100 / 53.9600
Day Range
Low 45.6250
High 49.6400
52 Week Range
Low 33.1500
High 65.5327
Volume
7,231,432
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Sector Update: Health Care Stocks Slide Late Afternoon, from 19 hours ago by MT Newswires
  19 hours ago by MT Newswires
  Companies Mentioned: HALO, EVO, EYEN, BLUE, CERO
  04:01 PM EST, 11/15/2024 (MT Newswires) -- Health care stocks fell late Friday afternoon with the NYSE Health Care Index declining 1.7% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.8%. The iShares Biotechnology ETF (IBB) slumped 4.7%...
- Sector Update: Health Care Stocks Retreat Friday Afternoon, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: HALO, NVAX, PFE, EVO, MRNA, CERO
  01:52 PM EST, 11/15/2024 (MT Newswires) -- Health care stocks fell Friday afternoon with the NYSE Health Care Index declining 1.5% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.6%. The iShares Biotechnology ETF (IBB) slumped 4.3%. In ...
- DJ Halozyme Therapeutics Down Over 13%, on Pace for Largest Percent Decrease Since January 2016 -- Data Talk, from 11:46AM ET on Friday Nov 15, 2024 by Dow Jones
  11:46AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: HALO
  
  Halozyme Therapeutics, Inc. (HALO) is currently at $46.88, down $7.08 or 13.12%
  
  --Would be lowest close since June 5, 2024, when it closed at $45.65
  
  --On pace for largest percent decrease since Jan. 13, 2016, when it fell 17.68%
- Halozyme Submits $2.11 Billion Acquisition Offer For Evotec, from 6:31AM ET on Friday Nov 15, 2024 by MT Newswires
  6:31AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: HALO, EVO
  06:31 AM EST, 11/15/2024 (MT Newswires) -- Halozyme Therapeutics (HALO) offered to acquire German drug maker Evotec (EVO) in a deal with an equity value of 2 billion euros ($2.11 billion). Halozyme submitted a non-binding proposal to Evotec's manage...
- DJ Evotec Shares Surge on $2.11 Billion Buyout Offer, from 3:56AM ET on Friday Nov 15, 2024 by Dow Jones
  3:56AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: HALO
  
  By Maitane Sardon
  
  Shares in Evotec rose after the company said Thursday that it received a takeover offer from U.S. biotechnology company Halozyme Therapeutics for about 2 billion euros ($2.11 billion).

Yesterday
- Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration, from 18 hours ago by Dow Jones
  18 hours ago by Dow Jones
  Companies Mentioned: EGRX
Nov 14, 2024
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 4:39PM ET on Thursday Nov 14, 2024 by Newsfile
  4:39PM ET on Thursday Nov 14, 2024 by Newsfile
  Companies Mentioned: ELTP
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 4:39PM ET on Thursday Nov 14, 2024 by Dow Jones
  4:39PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ELTP
Nov 13, 2024
- Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference, from 4:30PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:30PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: SUPN
Nov 12, 2024
- Supernus Pharmaceuticals Insider Sold Shares Worth $4,536,250, According to a Recent SEC Filing, from 4:30PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:30PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: SUPN
- Supernus Pharmaceuticals Insider Sold Shares Worth $391,568, According to a Recent SEC Filing, from 4:28PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:28PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: SUPN
- DJ Phibro Animal Health Is Maintained at Underweight by Barclays, from 10:15AM ET on Tuesday Nov 12, 2024 by Dow Jones
  10:15AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: PAHC
- Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: EGRX
Nov 8, 2024
- Supernus Pharmaceuticals Insider Sold Shares Worth $520,480, According to a Recent SEC Filing, from 4:18PM ET on Friday Nov 08, 2024 by MT Newswires
  4:18PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: SUPN
Nov 7, 2024
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024, from 7:02AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:02AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ELTP

Halozyme Therapeutics Inc
NASDAQ:HALOUnited States

Search Criteria

Yesterday

Sector Update: Health Care Stocks Slide Late Afternoon, from 19 hours ago by MT Newswires

Sector Update: Health Care Stocks Retreat Friday Afternoon, from 22 hours ago by MT Newswires

DJ Halozyme Therapeutics Down Over 13%, on Pace for Largest Percent Decrease Since January 2016 -- Data Talk, from 11:46AM ET on Friday Nov 15, 2024 by Dow Jones

Halozyme Submits $2.11 Billion Acquisition Offer For Evotec, from 6:31AM ET on Friday Nov 15, 2024 by MT Newswires

DJ Evotec Shares Surge on $2.11 Billion Buyout Offer, from 3:56AM ET on Friday Nov 15, 2024 by Dow Jones

Peers Headlines

Yesterday

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration, from 18 hours ago by Dow Jones

Nov 14, 2024

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 4:39PM ET on Thursday Nov 14, 2024 by Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 4:39PM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference, from 4:30PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

Supernus Pharmaceuticals Insider Sold Shares Worth $4,536,250, According to a Recent SEC Filing, from 4:30PM ET on Tuesday Nov 12, 2024 by MT Newswires

Supernus Pharmaceuticals Insider Sold Shares Worth $391,568, According to a Recent SEC Filing, from 4:28PM ET on Tuesday Nov 12, 2024 by MT Newswires

DJ Phibro Animal Health Is Maintained at Underweight by Barclays, from 10:15AM ET on Tuesday Nov 12, 2024 by Dow Jones

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 8, 2024

Supernus Pharmaceuticals Insider Sold Shares Worth $520,480, According to a Recent SEC Filing, from 4:18PM ET on Friday Nov 08, 2024 by MT Newswires

Nov 7, 2024

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024, from 7:02AM ET on Thursday Nov 07, 2024 by Dow Jones